COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,974 Articles (22,604 medRxiv, 8,370 bioRxiv)

Most recent first Previous |  Page 1996: Articles 19951-19960  | Next

Obesity as a predictor for adverse outcomes among COVID-19 patients: A meta-analysis
Das, P., Samad, N., Seidu, A.-A., Aboagye, R. G., Tetteh, J. K., Ahinkorah, B. O.
10.1101/2020.11.27.20239616 — Posted: 2020-11-30
Dietary supplements during the COVID-19 pandemic: insights from 1.4M users of the COVID Symptom Study app - a longitudinal app-based community survey
Louca, P., Murray, B., Klaser, K., Graham, M. S., Mazidi, M., Leeming, E. R., Thompson, E. J., Bowyer, R., Drew, D. A., Nguyen, L. A., Merino, J., Gomez, M. F., Mompeo, O., Costeira, R., Sudre, C. H., Gibson, R., Steves, C., Wolf, J., Franks, P. W., Ourselin, S., Chan, A. T., Berry, S. E., Valdes, A., Calder, P., Spector, T. D., Menni, C.
10.1101/2020.11.27.20239087 — Posted: 2020-11-30 Discussion: Onsite | Offsite
Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2
Huisman, J. S., Scire, J., Angst, D. C., Neher, R. A., Bonhoeffer, S., Stadler, T.
10.1101/2020.11.26.20239368 — Posted: 2020-11-30
Modelling the impact of health-related variables, age, migration, and socio-economic factors in the geographical distribution of early tested case-fatality risks associated with COVID-19 in Mexico
Ramirez-Aldana, R., Gomez-Verjan, J. C., Bello-Chavolla, O. Y., Garcia-Pena, C.
10.1101/2020.11.26.20239376 — Posted: 2020-11-30
Prevalence and stability of SARS CoV-2RNA on Bangladeshi banknotes
Akter, S., Roy, P. C., Ferdaus, A., Ibnat, H., Rubayet-Ul-Alam, A. S. M., Nigar, S., Jahid, I. K., Hossain, M. A.
10.1101/2020.11.26.20233627 — Posted: 2020-11-30
Quantifying superspreading for COVID-19 using Poisson mixture distributions
Kremer, C., Torneri, A., Boesmans, S., Meuwissen, H., Verdonschot, S., Vanden Driessche, K., Althaus, C. L., Faes, C., Hens, N.
10.1101/2020.11.27.20239657 — Posted: 2020-11-30
Predictors of QT Interval Prolongation in Critically-ill Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine
Scuotto, F., Marra, R., Almeida, L. L. d., Soares, M. S. R., Silva, G. K., Paul, L. C., Fenelon Costa, G. D., Cirenza, C.
10.1101/2020.11.26.20239418 — Posted: 2020-11-30
The evolving worldwide dynamic state of the COVID-19 outbreak
Vilar, J. M. G., Saiz, L.
10.1101/2020.11.26.20239434 — Posted: 2020-11-30
Risk exposures, risk perceptions, negative attitudes toward general vaccination, and COVID-19 vaccine acceptance among college students in South Carolina
Qiao, S., Tam, C. C., Li, X.
10.1101/2020.11.26.20239483 — Posted: 2020-11-30
The impact of the COVID-19 pandemic and related control measures on cancer diagnosis in Catalonia:A time-series analysis of primary care electronic health records covering about 5 million people.
Coma, E., Guiriguet, C., Mora, N., Marzo-Castillejo, M., Benitez, M., Mendez-Boo, L., Fina, F., Fabregas, M., Mercade, A., Medina, M.
10.1101/2020.11.26.20239202 — Posted: 2020-11-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).